Triple
T14201953
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Tuskegee syphilis study |
E351984
|
entity |
| Predicate | treatmentWithheld |
P113186
|
FINISHED |
| Object | penicillin |
E850002
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: penicillin | Statement: [Tuskegee syphilis study, treatmentWithheld, penicillin]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: penicillin Context triple: [Tuskegee syphilis study, treatmentWithheld, penicillin]
-
A.
penicillins
chosen
Penicillins are a widely used class of β-lactam antibiotics derived from Penicillium fungi, primarily effective against many Gram-positive bacteria.
-
B.
Opekta
Opekta was a German-Dutch company that produced and sold pectin-based gelling agents for making jam, notably managed in its Amsterdam branch by Anne Frank’s father, Otto Frank.
-
C.
Auscitain
An Auscitain is a resident or native of Auch, a historic town in the Occitanie region of southwestern France.
-
D.
diphtheria antitoxin
Diphtheria antitoxin is a serum-based immune therapy that neutralizes the toxin produced by Corynebacterium diphtheriae, used to treat and prevent the severe complications of diphtheria infection.
-
E.
Panazol
Panazol is a suburban commune in west-central France, located just east of the city of Limoges in the Nouvelle-Aquitaine region.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: treatmentWithheld Context triple: [Tuskegee syphilis study, treatmentWithheld, penicillin]
-
A.
hasReceivedTreatmentFor
Indicates that an entity has undergone or been given a treatment in relation to a specified condition, issue, or problem.
-
B.
subjectTreatment
Indicates that a subject is receiving, undergoing, or being administered a particular treatment or therapeutic intervention.
-
C.
hasSubjectTreatment
Indicates that a subject is receiving, has received, or is associated with a particular treatment or therapeutic intervention.
-
D.
usesTreatment
Indicates that one entity applies or employs a particular treatment or therapeutic method on or for another entity.
-
E.
subsequentTreatment
Indicates that one treatment occurs after and in response to a prior treatment or medical event.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d827894ac0819097803e57f3227b23 |
completed | April 9, 2026, 10:26 p.m. |
| NER | Named-entity recognition | batch_69de61f589a08190b71ad4e69d92ffd0 |
completed | April 14, 2026, 3:49 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69fd194f13688190af7ef5ceb92a73ff |
completed | May 7, 2026, 10:59 p.m. |
| PD | Predicate disambiguation | batch_69de05bcd7d48190a4848d9320404aa6 |
completed | April 14, 2026, 9:15 a.m. |
| PDg | Predicate description generation | batch_69de239a02e881909b0e2679487e4ab2 |
completed | April 14, 2026, 11:23 a.m. |
Created at: April 10, 2026, 1:05 a.m.